Trial Profile

Second Phase II clinical trial of AL001 for patients with mild to moderate Alzheimer's disease

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 14 May 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

07 May 2025 According to an Alzamend Neuro media release, the company announced its partnership with Mint Labs Inc. d/b/a QMENTA a leading medical imaging artificial intelligence company, to support its five upcoming Phase II clinical trials of AL001 at Massachusetts General Hospital.
25 Mar 2025 According to an Alzamend Neuro media release, the company plans to initiate the a highly anticipated phase II clinical study of AL001 for treatment of patients with Alzheimer's in the fourth quarter of 2025. This study follows the successful completion of a head coil by Tesla Dynamic Coils BV, a key component of the clinical trial.
27 Aug 2024 According to an Alzamend Neuro media release, the company announced partnership with Massachusetts General Hospital to conduct phase II clinical trials of AL001.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com